Analyst Research

Report Title Price
Provider: Stock Traders Daily
Provider: S&P Capital IQ Quantitative Report
Provider: Reuters Investment Profile
Provider: Thomson Reuters Stock Report

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Albany Molecular Research Inc completes acquisition of Oso Biopharmaceuticals Manufacturing

Tuesday, 1 Jul 2014 04:05pm EDT 

Albany Molecular Research Inc:Completes acquisition of Oso Biopharmaceuticals Manufacturing, former portfolio company of Altaris Capital Partners, LLC.Transaction is consistent with AMRI's strategy to be the preeminent supplier of custom and complex drug product development and manufacturing services to the pharmaceutical industry.Total consideration paid was $110 mln.AMRI financed transaction with cash on hand. 

Company Quote

0.14 +0.80%
27 Mar 2015